Timothy Daley
Stock Analyst at Wells Fargo
(2.03)
# 3,101
Out of 5,099 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $45.66 | +2.23% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $7.23 | +176.63% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $103.51 | -8.22% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $46.92 | +53.45% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $143.47 | +1.07% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,405.85 | -7.53% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $395.82 | -28.00% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $230.42 | +7.20% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $194.85 | +41.13% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $261.99 | +3.06% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $6.98 | +301.15% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $20.85 | +67.87% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $573.81 | -9.38% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.84 | +969.65% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $163.80 | +12.94% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $74.83 | +13.59% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $222.92 | -1.31% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $185.86 | +18.37% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $11.51 | +143.27% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $179.51 | -22.01% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $60.83 | +47.95% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $45.66
Upside: +2.23%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $7.23
Upside: +176.63%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $103.51
Upside: -8.22%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $46.92
Upside: +53.45%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $143.47
Upside: +1.07%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,405.85
Upside: -7.53%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $395.82
Upside: -28.00%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $230.42
Upside: +7.20%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $194.85
Upside: +41.13%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $261.99
Upside: +3.06%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $6.98
Upside: +301.15%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $20.85
Upside: +67.87%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $573.81
Upside: -9.38%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $0.84
Upside: +969.65%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $163.80
Upside: +12.94%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $74.83
Upside: +13.59%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $222.92
Upside: -1.31%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $185.86
Upside: +18.37%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $11.51
Upside: +143.27%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $179.51
Upside: -22.01%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $60.83
Upside: +47.95%